Hawaii Administrative Rules
Title 17 - DEPARTMENT OF HUMAN SERVICES
Department of Human Services
Chapter 1737 - SCOPE AND CONTENTS OF THE FEE FOR SERVICE MEDICAL ASSISTANCE PROGRAM
Subchapter 8 - TISSUE AND ORGAN TRANSPLANTATION
Section 17-1737-93 - Allogenic bone marrow transplant

Universal Citation: HI Admin Rules 17-1737-93

Current through February, 2024

(a) Indications for allogenic bone marrow transplant include:

(1) Severe aplastic anemia unresponsive to usual therapy;

(2) Acute myelogenous leukemia in first remission;

(3) Acute lymphocytic leukemia in second remission; and

(4) Chronic leukemia after first year.

(b) Conditions and limitations affecting allogenic bone marrow transplant include:

(1) Human leukocyte group A (HLA) histocompatible donor shall be available;

(2) Patient has no other major systemic disease which would result in poor potential for recovery (such as a heart condition, liver disease, kidney damage, brain lesions, cancer in other organs or lung disease);

(3) Patient shall have been properly evaluated by a qualified authority in Hawaii and bone marrow transplant is recommended as a possible curative procedure or if palliative, with reasonable likelihood for prolongation of life and return to an active life;

(4) No active infection at the time of the procedure;

(5) No general medical contraindication for the procedure and anesthesia;

(6) Informed consent shall be obtained from the patient or the patient's representative; and

(7) Age restricted to fifty or under except when identical twin is histocompatible and then age limit may be fifty-five.

Disclaimer: These regulations may not be the most recent version. Hawaii may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.